Sign in →

Test Code NIUC Nickel/Creatinine Ratio, Random, Urine


Specimen Required


Only orderable as part of a profile. For more information see NIUCR / Nickel/Creatinine Ratio, Random, Urine.

 

Patient Preparation:

High concentrations of gadolinium and iodine are known to potentially interfere with most inductively coupled plasma mass spectrometry-based metal tests. If either gadolinium- or iodine-containing contrast media has been administered, a specimen should not be collected for 96 hours.

Supplies: Urine Tubes, 10 mL (T068)

Container/Tube: Plastic, 10-mL urine tube or clean, plastic aliquot container with no metal cap or glued insert

Specimen Volume: 2.55 mL

Collection Instructions:

1. Collect a random urine specimen

2. See Metals Analysis Specimen Collection and Transport for complete instructions.


Useful For

Measurement of nickel concentration for biomonitoring nickel exposure

Method Name

Only orderable as part of a profile. For more information see NIUCR / Nickel/Creatinine Ratio, Random, Urine.

 

Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)

Reporting Name

Nickel/Creat Ratio, U

Specimen Type

Urine

Specimen Minimum Volume

1.35 mL

Specimen Stability Information

Specimen Type Temperature Time
Urine Refrigerated (preferred) 28 days
  Ambient  28 days
  Frozen  28 days

Reject Due To

  All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.

Clinical Information

Nickel is a highly abundant element with a silvery-white appearance. Nickel is frequently combined with other metals to form alloys and is essential for the catalytic activity of some plant and bacterial enzymes but has no known role in humans. Most nickel is used to make stainless steel.

 

Nickel and its compounds have no characteristic odor or taste. Nickel compounds are used for nickel plating, to color ceramics, to make some batteries, and as catalysts that increase the rate of chemical reactions. One of the most toxic nickel compounds is nickel carbonyl, Ni(CO)4, which is used as a catalyst in petroleum refining and in the plastics industry, is frequently employed in the production of metal alloys (which are popular for their anticorrosive and hardness properties), in nickel-cadmium rechargeable batteries, and is used as a catalyst in hydrogenation of oils. Ni(CO)4 is very toxic and is lipid soluble, allowing it to cross cell membranes.

 

Occupational exposure to nickel occurs primarily via inhalation of nickel compounds. Inhalation of dust high in nickel content has been associated with development of lung and nasal cancer.

 

Food is the major source of exposure to nickel. Foods naturally high in nickel include chocolate, soybeans, nuts, and oatmeal. Individuals may also be exposed to nickel by breathing air, drinking water, or smoking tobacco containing nickel. Stainless steel and coins contain nickel. Some jewelry is plated with nickel or made from nickel alloys. Patients may be exposed to nickel in implanted devices including joint prostheses, sutures, clips, and screws made from nickel -containing alloys.

 

The most common harmful health effect of Ni in humans is an allergic reaction. Approximately 10% to 20% of the population is sensitive to it. The most serious harmful health effects from exposure to nickel, such as chronic bronchitis, reduced lung function, and cancer of the lung and nasal sinus, have occurred in people who have breathed dust containing certain nickel compounds while working in nickel refineries or nickel -processing plants. Urine is the specimen of choice for the determination of nickel exposure, but serum concentrations can be used to verify an elevated urine concentration.

 

Patients undergoing dialysis are exposed to nickel and accumulate nickel in blood and other organs; there appear to be no adverse health effects from this exposure. Hypernickelemia has been observed in patients undergoing kidney dialysis. At the present time, this is considered to be an incidental finding as no correlation with toxic events has been identified. Routine monitoring of patients undergoing dialysis is currently not recommended.

Reference Values

Only orderable as part of a profile. For more information see NIUCR / Nickel/Creatinine Ratio, Random, Urine.

 

0-17 years: Not established

Males ≥18 years: <3.8 mcg/g creatinine

Females ≥18 years: <4.3 mcg/g creatinine

Day(s) Performed

Thursday

Specimen Retention Time

14 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

LOINC Code Information

Test ID Test Order Name Order LOINC Value
NIUC Nickel/Creat Ratio, U 13472-6

 

Result ID Test Result Name Result LOINC Value
614553 Nickel/Creat Ratio, U 13472-6

Report Available

2 to 8 days